Published in J Autism Dev Disord on December 01, 2005
Incidence of gastrointestinal symptoms in children with autism: a population-based study. Pediatrics (2009) 2.12
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord (2008) 1.46
Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med (2010) 1.41
Does nutritional intake differ between children with autism spectrum disorders and children with typical development? J Autism Dev Disord (2008) 1.29
Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology (2011) 1.15
Development and validation of an inventory to assess mealtime behavior problems in children with autism. J Autism Dev Disord (2007) 1.05
Complementary and alternative medicine treatments for children with autism spectrum disorders. Child Adolesc Psychiatr Clin N Am (2008) 1.01
Autism and coeliac disease. J Autism Dev Disord (2007) 0.92
Immune dysregulation in autism spectrum disorder. Eur J Pediatr (2013) 0.88
A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. J Autism Dev Disord (2009) 0.87
Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism. Eur J Hum Genet (2009) 0.84
Molecular handoffs in nitrergic neurotransmission. Front Med (Lausanne) (2014) 0.83
Brief report: "allergic symptoms" in children with Autism Spectrum Disorders. More than meets the eye? J Autism Dev Disord (2011) 0.83
Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study. J Autism Dev Disord (2008) 0.82
Constipation in children with autism and autistic spectrum disorder. Pediatr Surg Int (2010) 0.81
Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. J Child Adolesc Psychopharmacol (2011) 0.80
Brief report: normal intestinal permeability at elevated platelet serotonin levels in a subgroup of children with pervasive developmental disorders in Curaçao (The Netherlands antilles). J Autism Dev Disord (2007) 0.80
The phenomenology of autistic regression: subtypes and associated factors. Eur Child Adolesc Psychiatry (2011) 0.80
Pathophysiology of autism spectrum disorders: revisiting gastrointestinal involvement and immune imbalance. World J Gastroenterol (2014) 0.79
Low Serum Alpha-1 Antitrypsin (AAT) in Family Members of Individuals with Autism Correlates with PiMZ Genotype. Biomark Insights (2009) 0.78
Serological screening for Celiac Disease in 382 pre-schoolers with Autism Spectrum Disorder. Ital J Pediatr (2016) 0.75
Can urinary indolylacroylglycine (IAG) levels be used to determine whether children with autism will benefit from dietary intervention? Pediatr Res (2016) 0.75
The Impact of Health Problems on Behavior Problems in Adolescents and Adults With Autism Spectrum Disorders: Implications for Maternal Burden. Soc Work Ment Health (2010) 0.75
What is regressive autism and why does it occur? Is it the consequence of multi-systemic dysfunction affecting the elimination of heavy metals and the ability to regulate neural temperature? N Am J Med Sci (2009) 0.75
Breast Milk Protects Against Gastrointestinal Symptoms in Infants at High Risk for Autism During Early Development. J Pediatr Gastroenterol Nutr (2016) 0.75
Retracted Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet (1998) 36.93
Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N Engl J Med (1999) 4.63
Measles, mumps, and rubella vaccination and bowel problems or developmental regression in children with autism: population study. BMJ (2002) 3.01
Gastrointestinal abnormalities in children with autistic disorder. J Pediatr (1999) 2.96
Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis (2002) 2.80
Retracted Enterocolitis in children with developmental disorders. Am J Gastroenterol (2000) 2.70
Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol (2000) 2.50
Secretin and autism: a two-part clinical investigation. J Autism Dev Disord (2000) 2.27
Potential viral pathogenic mechanism for new variant inflammatory bowel disease. Mol Pathol (2002) 2.07
No evidence for a new variant of measles-mumps-rubella-induced autism. Pediatrics (2001) 1.76
Relation of childhood gastrointestinal disorders to autism: nested case-control study using data from the UK General Practice Research Database. BMJ (2002) 1.69
An assessment of food acceptance in children with autism or pervasive developmental disorder-not otherwise specified. J Autism Dev Disord (2001) 1.68
Detection and sequencing of measles virus from peripheral mononuclear cells from patients with inflammatory bowel disease and autism. Dig Dis Sci (2000) 1.67
Small intestinal enteropathy with epithelial IgG and complement deposition in children with regressive autism. Mol Psychiatry (2002) 1.67
Disruption of sulphated glycosaminoglycans in intestinal inflammation. Lancet (1993) 1.64
Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. Pediatrics (2001) 1.62
A randomized, double-blind, placebo-controlled trial of porcine versus synthetic secretin for reducing symptoms of autism. J Am Acad Child Adolesc Psychiatry (2002) 1.59
Abnormal intestinal permeability in children with autism. Acta Paediatr (1996) 1.48
Correlates of specific childhood feeding problems. J Paediatr Child Health (2003) 1.44
Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology (2002) 1.40
Autistic disorder and gastrointestinal disease. Curr Opin Pediatr (2002) 1.40
Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys (1998) 1.36
Colonic CD8 and gamma delta T-cell infiltration with epithelial damage in children with autism. J Pediatr (2001) 1.21
Application of a ketogenic diet in children with autistic behavior: pilot study. J Child Neurol (2003) 1.19
Autism and gastrointestinal symptoms. Curr Gastroenterol Rep (2002) 1.16
Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J Am Acad Child Adolesc Psychiatry (2001) 1.14
A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci (2002) 1.09
Oral famotidine: a potential treatment for children with autism. Med Hypotheses (1997) 1.08
Perspectives on the nutritional ecology of autistic children. J Autism Dev Disord (1986) 1.06
Sulphation deficit in "low-functioning" autistic children: a pilot study. Biol Psychiatry (1999) 1.02
Effect of secretin on children with autism: a randomized controlled trial. Dev Med Child Neurol (2000) 1.00
Pica and elevated blood lead level in autistic and atypical children. Am J Dis Child (1976) 0.98
Autism and celiac disease: failure to validate the hypothesis that a link might exist. Biol Psychiatry (1997) 0.98
Gluten and casein free diets in autism: a study of the effects on food choice and nutrition. J Hum Nutr Diet (2002) 0.97
A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J Pediatr (2001) 0.97
Lymphonodular hyperplasia on the mucosa of the lower gastrointestinal tract in children: an indication of enhanced immune response? J Pediatr Gastroenterol Nutr (2002) 0.96
Review article: the concept of entero-colonic encephalopathy, autism and opioid receptor ligands. Aliment Pharmacol Ther (2002) 0.93
Food allergy and infantile autism. Panminerva Med (1995) 0.92
Minerals in the hair and nutrient intake of autistic children. J Autism Dev Disord (1982) 0.89
Efficacy of porcine secretin in children with autism and pervasive developmental disorder. J Autism Dev Disord (2002) 0.88
Alpha-1-antitrypsin, autism, and coeliac disease. Lancet (1972) 0.88
Lack of benefit of intravenous synthetic human secretin in the treatment of autism. J Autism Dev Disord (2002) 0.87
Autism and the gastrointestinal tract. Am J Gastroenterol (2000) 0.85
Constipation with acquired megarectum in children with autism. Pediatrics (2003) 0.85
How common are gastrointestinal disorders in children with autism? Curr Opin Pediatr (2003) 0.84
Double-blind placebo-controlled trial of secretin: effects on aberrant behavior in children with autism. J Autism Dev Disord (2002) 0.84
A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism. Clin Pediatr (Phila) (2001) 0.84
Multiple doses of secretin in the treatment of autism: a controlled study. Acta Paediatr (2002) 0.83
Constipation in children. N Engl J Med (1998) 0.82
Secretin treatment for autistic disorder: a critical analysis. Pharmacotherapy (2002) 0.81
Response of intestinal mucosa to gluten challenge in autistic subjects. Lancet (1979) 0.81
Secretin and sleep in children with autism. Child Psychiatry Hum Dev (2002) 0.80
Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design. J Neural Transm (Vienna) (2001) 0.79
Disruptive behavior: a dietary approach. J Autism Child Schizophr (1978) 0.79
Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study. Pediatrics (2001) 0.78
Toilet training and behaviors of people with autism: parent views. J Autism Dev Disord (1992) 0.77
The abdominal brain and enteric nervous system. J Altern Complement Med (1999) 0.76
Commentary: the primacy of the scientific method. J Am Acad Child Adolesc Psychiatry (2002) 0.75
Toddler diarrhoea: more a nutritional disorder than a disease. Arch Dis Child (1998) 0.75
MMR vaccination, ileal lymphoid nodular hyperplasia, and pervasive develop-mental disorder. Lancet (2002) 0.75
Risks with controlling diet. J Autism Dev Disord (1979) 0.75
Use of secretin in the treatment of childhood autism. Med Sci Monit (2002) 0.75
Functional impact of global rare copy number variation in autism spectrum disorders. Nature (2010) 14.66
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
A genome-wide scan for common alleles affecting risk for autism. Hum Mol Genet (2010) 3.42
Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry (2005) 2.94
Individual common variants exert weak effects on the risk for autism spectrum disorderspi. Hum Mol Genet (2012) 2.46
Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin Gastroenterol Hepatol (2008) 2.19
Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. J Abnorm Child Psychol (2007) 1.98
Obese children with steatohepatitis can develop cirrhosis in childhood. Am J Gastroenterol (2002) 1.72
Risperidone and adaptive behavior in children with autism. J Am Acad Child Adolesc Psychiatry (2006) 1.71
Validity of the autism diagnostic interview-revised. Am J Ment Retard (2006) 1.66
Defining pediatric malnutrition: a paradigm shift toward etiology-related definitions. JPEN J Parenter Enteral Nutr (2013) 1.65
Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. J Am Acad Child Adolesc Psychiatry (2006) 1.61
Cytokine expression in normal and inflamed esophageal mucosa: a study into the pathogenesis of allergic eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2006) 1.56
Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics (2003) 1.56
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. J Am Acad Child Adolesc Psychiatry (2009) 1.55
Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry (2002) 1.53
Complications after outpatient upper GI endoscopy in children: 30-day follow-up. Am J Gastroenterol (2003) 1.50
Onset and exacerbation of obsessive-compulsive disorder in pregnancy and the postpartum period. J Clin Psychiatry (2010) 1.47
Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. J Autism Dev Disord (2008) 1.46
Accuracy and tolerability of the Bravo catheter-free pH capsule in patients between the ages of 4 and 18 years. J Pediatr Gastroenterol Nutr (2007) 1.44
Screening for celiac disease in asymptomatic children with Down syndrome: cost-effectiveness of preventing lymphoma. Pediatrics (2006) 1.43
A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorder. Hum Genet (2011) 1.43
Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects. Neuropsychopharmacology (2004) 1.41
A pilot study of D-cycloserine in subjects with autistic disorder. Am J Psychiatry (2004) 1.40
Autism: the micro-movement perspective. Front Integr Neurosci (2013) 1.32
Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol (2007) 1.28
Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management. Paediatr Drugs (2004) 1.26
Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol (2005) 1.24
Neurochemistry in the pathophysiology of autism. J Clin Psychiatry (2005) 1.23
Structural and functional magnetic resonance imaging of autism spectrum disorders. Brain Res (2010) 1.22
A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders. J Child Adolesc Psychopharmacol (2004) 1.20
Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) (2013) 1.19
Atypical antipsychotics in children and adolescents with autistic and other pervasive developmental disorders. J Clin Psychiatry (2008) 1.19
Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biol Psychiatry (2006) 1.18
High nitric oxide production in autistic disorder: a possible role for interferon-gamma. Biol Psychiatry (2004) 1.18
A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) (2006) 1.18
Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data. Am J Psychiatry (2004) 1.16
Age-specific questionnaires distinguish GERD symptom frequency and severity in infants and young children: development and initial validation. J Pediatr Gastroenterol Nutr (2005) 1.16
Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. J Child Adolesc Psychopharmacol (2010) 1.15
Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases. J Child Adolesc Psychopharmacol (2004) 1.15
Pharmacotherapy to control behavioral symptoms in children with autism. Expert Opin Pharmacother (2012) 1.12
Developing drugs for core social and communication impairment in autism. Child Adolesc Psychiatr Clin N Am (2008) 1.10
White specks in the esophageal mucosa: An endoscopic manifestation of non-reflux eosinophilic esophagitis in children. Gastrointest Endosc (2004) 1.09
Exploring potential noninvasive biomarkers in eosinophilic esophagitis in children. J Pediatr Gastroenterol Nutr (2011) 1.09
Aripiprazole for maladaptive behavior in pervasive developmental disorders. J Child Adolesc Psychopharmacol (2004) 1.09
Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders. Neuropsychopharmacology (2002) 1.08
High blood monocyte counts and neopterin levels in children with autistic disorder. Am J Psychiatry (2003) 1.07
Maternal folic acid supplementation and risk of autism. JAMA (2013) 1.07
Pharmacologic treatment of autism and related disorders. Pediatr Ann (2007) 1.07
Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study. J Child Adolesc Psychopharmacol (2009) 1.06
Antipsychotics in the treatment of autism. J Clin Invest (2008) 1.06
The amygdala and related structures in the pathophysiology of autism. Pharmacol Biochem Behav (2002) 1.05
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. J Am Acad Child Adolesc Psychiatry (2011) 1.05
Open-label memantine in fragile X syndrome. J Autism Dev Disord (2009) 1.04
The use of selective serotonin reuptake inhibitors in autism and related disorders. J Child Adolesc Psychopharmacol (2006) 1.04
Severity of basal cell hyperplasia differs in reflux versus eosinophilic esophagitis. J Pediatr Gastroenterol Nutr (2006) 1.03
Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Curr Treat Options Neurol (2010) 1.02
Exploring the manifestations of anxiety in children with autism spectrum disorders. J Autism Dev Disord (2013) 1.02
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 1.02
Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biol Psychiatry (2007) 1.00
Serotoninergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today (2008) 1.00
Brief report: autistic disorder in three children with cytomegalovirus infection. J Autism Dev Disord (2004) 0.99